Grown Rogue International (GRUSF) Other Operating Expenses (2009 - 2026)
Grown Rogue International (GRUSF) posted quarterly Other Operating Expenses of $246156.0 for Q1 2026, up 100.0% quarter-over-quarter from -$2324.3 billion in Q4 2025.
Grown Rogue International (GRUSF) Other Operating Expenses (2009 - 2026) Analysis & Trends
Grown Rogue International's Other Operating Expenses history runs 17 years deep, the most recent figure standing at $246156.0 for Q1 2026.
- In Q1 2026, Other Operating Expenses changed N/A year-over-year to $246156.0; the TTM figure through Mar 2026 stood at -$1675.6 billion (down 918541360.49% YoY), while the FY2025 annual figure was $3.1 million, up 59.71% from the prior year.
- Other Operating Expenses for Q1 2026 stood at $246156.0, up from -$2324.3 billion in the prior quarter.
- The five-year high for Other Operating Expenses was $648.6 billion in Q3 2025, with the low at -$2324.3 billion in Q4 2025.
- The 5-year median for Other Operating Expenses is $144186.5 (2023), against an average of -$139.6 billion.
- The sharpest annual moves came in 2022 and 2025: Other Operating Expenses slumped 101.06% in 2022, then soared 8848263764.37% in 2025.
- Grown Rogue International's Other Operating Expenses stood at -$5440.0 in 2022, then soared by 1013.2% to $49678.0 in 2023, then sank by 85.24% to $7330.5 in 2024, then plunged by 31706542508.12% to -$2324.3 billion in 2025, then surged by 100.0% to $246156.0 in 2026.
- Business Quant data shows GRUSF's Other Operating Expenses at $246156.0 in Q1 2026, -$2324.3 billion in Q4 2025, and $648.6 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - |
| 10 | Grown Rogue International | 114.97 Mn | 109.89 Mn | 5.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 214,737.00 |
| Mar 31, 2026 | 246,156.00 |
| Dec 31, 2025 | -2,324.26 Bn |
| Sep 30, 2025 | 648.63 Bn |
| Sep 30, 2024 | 7,330.53 |
| Jun 30, 2024 | 175,092.81 |
| Mar 31, 2024 | 118,450.00 |
| Dec 31, 2023 | 49,678.00 |
| Oct 31, 2023 | -10,237.15 |
| Jul 31, 2023 | 220,292.14 |
| Apr 30, 2023 | 169,923.00 |
| Jan 31, 2023 | 223,774.00 |
| Jan 31, 2022 | -5,440.00 |
| Jul 31, 2021 | -7,573.00 |
| Apr 30, 2021 | 454,197.00 |
| Jan 31, 2021 | 514,778.00 |
| Oct 31, 2020 | 3,810.00 |
| Jul 31, 2020 | -4,024.00 |
| Apr 30, 2020 | -5,954.00 |
| Jan 31, 2020 | -701,559.00 |